Subscribe To
GMDA / Penny Stocks To Buy Now? 3 To Watch In The Stock Market Today
GMDA News
By Seeking Alpha
August 14, 2023
Gamida Cell: The Treacherous Path To Profitability
Gamida Cell's approved therapy, Omisirge, shows faster neutrophil recovery and reduced infections in blood cancer patients compared to standard care. more_horizontal
By Zacks Investment Research
June 9, 2023
Gamida Cell (GMDA)'s Technical Outlook is Bright After Key Golden Cross
Gamida Cell Ltd. (GMDA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. more_horizontal
By Seeking Alpha
May 15, 2023
Gamida Cell Ltd. (GMDA) Q1 2023 Earnings Call Transcript
Gamida Cell Ltd. (NASDAQ:GMDA ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Mike Kuczkowski - Corporate Communication more_horizontal
By Business Wire
May 11, 2023
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced tha more_horizontal
By PennyStocks
May 10, 2023
Penny Stocks To Buy Now? 3 To Watch In The Stock Market Today
Penny stocks with unusual options activity today The post Penny Stocks To Buy Now? 3 To Watch In The Stock Market Today appeared first on Penny Stocks more_horizontal
By InvestorPlace
April 19, 2023
Why Is Gamida Cell (GMDA) Stock Down 19% Today?
Gamida Cell (NASDAQ: GMDA ) stock is falling on Wednesday after the cell therapy company revealed details of a public securities offering. According t more_horizontal
By MarketBeat
April 18, 2023
Gamida Cell Stock Jumps Over 100% on FDA Approval
Gamida Cell Ltd. (NASDAQ: GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fi more_horizontal
By Proactive Investors
April 18, 2023
Gamida Cell shares jump on FDA recognition of allogeneic cell therapy
Gamida Cell shares shot higher on Tuesday after its allogeneic cell therapy received US Food and Drug Administration (FDA) approval. Its drug candidat more_horizontal